Cover Image
Market Research Report
Product code
243086

Stem Cells

Published: | Global Industry Analysts, Inc. | 162 Pages | Delivery time: 1-2 business days

Price

Back to Top
Stem Cells
Published: April 1, 2021
Global Industry Analysts, Inc.
Content info: 162 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Abstract:

Global Stem Cells Market to Reach $15.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Stem Cells estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$12.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 6.9% CAGR

The Stem Cells market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.

Select Competitors (Total 66 Featured) -

  • apceth Biopharma GmbH
  • Athersys Inc.
  • AVIVA BioSciences Corporation
  • BioE Inc.
  • Bone Therapeutics SA
  • Cesca Therapeutics Inc.
  • Cryo-Cell International Inc.
  • Cytori Therapeutics Inc.
  • ESI BIO
  • Gamida Cell Ltd.
  • Holostem Terapie Avanzate
  • International Stem Cell Corp.
  • Kangstem Biotech. Ltd.
  • Lonza Group Ltd.
  • Mesoblast Ltd.
  • Neuralstem Inc.
  • Nuvasive Inc.
  • OncoMed Pharmaceuticals Inc.
  • Osiris Therapeutics Inc.
  • Promethera Biosciences S.A.N.V
  • Reliance Life Sciences
  • ReNeuron Group Plc.
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takara Bio USA Inc.
  • TiGenix NV
  • U.S Stem Cell Inc.
  • ViaCord
Table of Contents
Product Code: MCP-6142

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries
    • Recent Market Activity
    • Select Approved Stem Cell Products
    • Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
    • Trends Related to Stem Cell Clinical Trials
    • Select Stem Cell Pipeline Analysis
    • Current & Future Analysis
    • Stem Cell Research Funding Policies across the World
    • Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research
    • Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications
    • Dental Mesenchymal Stem Cells - Emergence of a Niche Market
    • For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research
    • Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern
  • 2. FOCUS ON SELECT PLAYERS
    • Athersys, Inc. (USA)
    • Apceth GmbH & Co.KG (Germany)
    • AVIVA BioSciences Corporation (USA)
    • BioE, Inc. (USA)
    • Bone Therapeutics SA (Belgium)
    • Cesca Therapeutics, Inc. (USA)
    • Cryo-Cell International, Inc. (USA)
    • Cytori Therapeutics, Inc. (USA)
    • ESI BIO, a Division of BioTime Inc. (USA)
    • Gamida Cell Ltd. (Israel)
    • Holostem Terapie Avanzate (Italy)
    • International Stem Cell Corporation (USA)
    • Kangstem Biotech., Ltd. (Korea)
    • Lonza Group Ltd (Switzerland)
    • Mesoblast Ltd. (Australia)
    • Neuralstem, Inc. (USA)
    • Nuvasive, Inc. (USA)
    • Osiris Therapeutics, Inc. (USA)
    • OncoMed Pharmaceuticals, Inc (USA)
    • PROMETHERA Biosciences S.A.N.V (Belgium)
    • Reliance Life Sciences (India)
    • ReNeuron Group Plc. (UK)
    • STEMCELL Technologies, Inc. (Canada)
    • Stemedica Cell Technologies, Inc (USA)
    • Stempeutics Research Pvt. Ltd. (India)
    • Takara Bio USA Inc (USA)
    • TiGenix NV (Belgium)
    • U.S Stem Cell, Inc. (USA)
    • ViaCord, LLC (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells
    • Embryonic Stem Cell Gene Nanog Found to Reverse Aging
    • Canadian and Dutch Scientists Finds the "Genetic Switch" to Increase Stem Cell Volume from Cord Blood
    • The Boston Program Pioneers Cell-based Personalized Diabetes Treatment
    • iPSCs Provide Valuable Source for Retinal Transplants and Other Applications
    • Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders
    • Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients?
    • Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted
    • Adverse Reactions of Stem Cell-Face Lift Therapy
    • Stem Cell-Breast Enhancement
    • Other Innovations Using Stem Cells
    • New Stem Cell Software & Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 11: USA Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 12: USA 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 13: USA Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 14: USA 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • CANADA
    • TABLE 15: Canada Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 16: Canada 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 17: Canada Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 18: Canada 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • JAPAN
    • TABLE 19: Japan Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: Japan 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 21: Japan Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 22: Japan 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • CHINA
    • TABLE 23: China Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 24: China 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 25: China Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: China 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • EUROPE
    • TABLE 27: Europe Current & Future Analysis for Stem Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 28: Europe 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 29: Europe Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 30: Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 31: Europe Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • FRANCE
    • TABLE 33: France Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 34: France 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 35: France Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 36: France 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • GERMANY
    • TABLE 37: Germany Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Germany 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 39: Germany Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 40: Germany 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • ITALY
    • TABLE 41: Italy Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 42: Italy 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 43: Italy Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Italy 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 45: UK Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 46: UK 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 47: UK Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 48: UK 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Rest of Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 51: Rest of Europe Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Rest of Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 53: Asia-Pacific Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Asia-Pacific 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 55: Asia-Pacific Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Asia-Pacific 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 57: Rest of World Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 58: Rest of World 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 59: Rest of World Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Rest of World 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 66